Binance rejects allegations of $1.7 billion in Iran-linked crypto flows, telling a U.S. Senate panel it found no evidence of direct transactions with the regimeBinance rejects allegations of $1.7 billion in Iran-linked crypto flows, telling a U.S. Senate panel it found no evidence of direct transactions with the regime

Binance Denies Direct Iran Crypto Flows in Response to U.S. Senate Probe

2026/03/06 23:38
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Binance, the world's largest cryptocurrency exchange, has formally responded to an inquiry from the U.S. Senate Permanent Subcommittee on Investigations regarding allegations of massive sanctions evasion. In a letter dated March 6, 2026, the exchange's legal representatives asserted that an exhaustive internal review found no evidence of accounts on its platform transacting directly with Iranian entities. This response marks a significant pushback against regulatory pressure following a period of intense scrutiny over the exchange's crypto news footprint and historical compliance record.

Addressing the $1.7 Billion Allegation

The exchange's response directly addresses concerns raised by Senator Richard Blumenthal (D-Conn.) concerning reports that roughly $1.7 billion in digital assets had flowed to Iran-linked groups. Binance characterized these reports as "demonstrably false" and "defamatory," emphasizing that its internal monitoring systems are designed to prevent exactly the type of illicit activity described in recent media investigations. The exchange maintains that the figures cited in the probe overstate the actual exposure and misinterpret the nature of blockchain data.

Defining Direct vs. Indirect Transactions

In the context of global finance, Direct Transactions involve a primary transfer between a user account and a sanctioned entity. Indirect Exposure, which Binance admitted to finding, occurs when funds pass through multiple intermediate wallets before eventually interacting with a flagged address. This distinction is critical in digital asset compliance; while direct flows indicate a failure of KYC (Know Your Customer) protocols, indirect flows often highlight the inherent difficulty of tracking assets across a decentralized ecosystem. You can see how these flows impact major assets like Bitcoin prices during periods of regulatory uncertainty.

From Media Reports to Internal Audit Facts

The Senate probe was sparked by investigative reports from major outlets like the New York Times and the Wall Street Journal. These reports suggested that Binance's own compliance staff had identified nearly $2 billion in transfers involving two specific partners: Hexa Whale and Blessed Trust.

Binance’s March 6 letter clarifies several specific points:

  • No Direct Links: No Binance account was found to have a direct financial relationship with the Iranian government or its proxies.
  • Proactive Investigations: The concerns regarding Hexa Whale and Blessed Trust were identified following a proactive internal review triggered by law enforcement inquiries.
  • Account Termination: Once the indirect exposure was confirmed, Binance removed the associated entities from its platform.
  • Staff Retention: The exchange rejected claims that compliance personnel were fired for flagging these transactions, maintaining that departures were unrelated to the Iran investigation.

Navigating Compliance and Third-Party Risks

A significant portion of the allegations centered on "vendor accounts" and partners acting as conduits. According to the Senate inquiry, these intermediaries allegedly allowed sanctioned Iranian individuals to access over 1,500 Binance accounts. Binance argues that it maintains a rigorous compliance protocol and that any breach of these rules by third-party vendors resulted in the immediate termination of those partnerships. Users interested in the security of their assets often turn to an exchange comparison to evaluate which platforms offer the most robust regulatory safeguards.

Market Opportunity
Union Logo
Union Price(U)
$0.001055
$0.001055$0.001055
+3.53%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09